Amphastar Pharmaceuticals AMPH Increase Decrease In Income Tax Refund Deposits And Payable
Increase Decrease In Income Tax Refund Deposits And Payable at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept amph:IncreaseDecreaseInIncomeTaxRefundDepositsAndPayable.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's increase decrease in income tax refund deposits and payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's increase decrease in income tax refund deposits and payable?
- Amphastar Pharmaceuticals (AMPH) reported increase decrease in income tax refund deposits and payable of -$7.74M in Q1 2026.
- How has Amphastar Pharmaceuticals's increase decrease in income tax refund deposits and payable changed year-over-year?
- Amphastar Pharmaceuticals's increase decrease in income tax refund deposits and payable decreased by 19.7% year-over-year, from -$6.47M to -$7.74M.
- What is the long-term trend for Amphastar Pharmaceuticals's increase decrease in income tax refund deposits and payable?
- Over 2 years (2021 to 2024), Amphastar Pharmaceuticals's increase decrease in income tax refund deposits and payable has grown at a -9.5% compound annual growth rate (CAGR), from -$8.35M to -$6.83M.
- What does increase decrease in income tax refund deposits and payable mean?
- This metric measures the net change in cash deposits held for tax purposes or expected tax refunds due from government authorities. It represents a temporary movement of cash between the company and tax jurisdictions based on estimated tax payments versus actual liabilities. Monitoring this helps investors understand the timing of tax-related cash flows and the company's working capital efficiency regarding tax assets.